Page last updated: 2024-10-24

carvedilol and Aspergillosis, Allergic Bronchopulmonary

carvedilol has been researched along with Aspergillosis, Allergic Bronchopulmonary in 1 studies

Aspergillosis, Allergic Bronchopulmonary: Hypersensitivity reaction (ALLERGIC REACTION) to fungus ASPERGILLUS in an individual with long-standing BRONCHIAL ASTHMA. It is characterized by pulmonary infiltrates, EOSINOPHILIA, elevated serum IMMUNOGLOBULIN E, and skin reactivity to Aspergillus antigen.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Knight, JM1
Mak, G1
Shaw, J1
Porter, P1
McDermott, C1
Roberts, L1
You, R1
Yuan, X1
Millien, VO1
Qian, Y1
Song, LZ1
Frazier, V1
Kim, C1
Kim, JJ1
Bond, RA1
Milner, JD1
Zhang, Y1
Mandal, PK1
Luong, A1
Kheradmand, F1
McMurray, JS1
Corry, DB1

Other Studies

1 other study available for carvedilol and Aspergillosis, Allergic Bronchopulmonary

ArticleYear
Long-Acting Beta Agonists Enhance Allergic Airway Disease.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Anti-Asthmatic Agents; Arrestins; Aspergill

2015